MX9804828A - Benzotiazolona etanaminas biologicamente activas. - Google Patents

Benzotiazolona etanaminas biologicamente activas.

Info

Publication number
MX9804828A
MX9804828A MX9804828A MX9804828A MX9804828A MX 9804828 A MX9804828 A MX 9804828A MX 9804828 A MX9804828 A MX 9804828A MX 9804828 A MX9804828 A MX 9804828A MX 9804828 A MX9804828 A MX 9804828A
Authority
MX
Mexico
Prior art keywords
ethanamines
biologically active
benzothiazolone
active benzothiazolone
halogen
Prior art date
Application number
MX9804828A
Other languages
English (en)
Inventor
Roger Bonnert
Roger Brown
Peter Cage
David Cheshire
Francis Ince
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of MX9804828A publication Critical patent/MX9804828A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

La presente invencion se refiere a compuestos de la formula I, en donde X representa naftilo sustituido opcionalmente por alquilo o halogeno; y p, q y r representan, independientemente, 2 o 3, y a las sales farmacéuticamente aceptables de los mismos; a procesos para su preparacion y a métodos para su uso.
MX9804828A 1995-12-23 1998-06-16 Benzotiazolona etanaminas biologicamente activas. MX9804828A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9526511.2A GB9526511D0 (en) 1995-12-23 1995-12-23 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
MX9804828A true MX9804828A (es) 1998-09-30

Family

ID=10786064

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9804828A MX9804828A (es) 1995-12-23 1998-06-16 Benzotiazolona etanaminas biologicamente activas.

Country Status (27)

Country Link
US (1) US5929100A (es)
EP (1) EP0918760B1 (es)
JP (1) JP2000502681A (es)
KR (1) KR19990076688A (es)
CN (1) CN1072214C (es)
AR (1) AR005008A1 (es)
AT (1) ATE209638T1 (es)
AU (1) AU704506B2 (es)
BR (1) BR9612234A (es)
CA (1) CA2238877A1 (es)
CZ (1) CZ288704B6 (es)
DE (1) DE69617472D1 (es)
EE (1) EE03440B1 (es)
GB (1) GB9526511D0 (es)
HU (1) HUP9900100A3 (es)
IL (2) IL124998A0 (es)
IS (1) IS4759A (es)
MX (1) MX9804828A (es)
NO (1) NO982927D0 (es)
NZ (1) NZ325500A (es)
PL (1) PL327475A1 (es)
RU (1) RU2177476C2 (es)
SK (1) SK82098A3 (es)
TR (1) TR199801196T2 (es)
TW (1) TW401411B (es)
WO (1) WO1997023470A1 (es)
ZA (1) ZA9610354B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (fr) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
CA2543858C (en) 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EA201001747A1 (ru) 2008-06-18 2011-08-30 Астразенека Аб Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
EP0180994A3 (en) * 1984-11-08 1987-09-23 Syntex (U.S.A.) Inc. Antihypertensive dialkyl aminoethylaniline derivatives
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
US5648370A (en) * 1990-11-20 1997-07-15 Astra Pharmaceuticals Limited 7-(2-aminoethyl) benzothiazolones

Also Published As

Publication number Publication date
DE69617472D1 (de) 2002-01-10
ATE209638T1 (de) 2001-12-15
AR005008A1 (es) 1999-04-07
ZA9610354B (en) 1997-06-23
AU1402597A (en) 1997-07-17
PL327475A1 (en) 1998-12-07
TR199801196T2 (xx) 1998-10-21
IL124998A0 (en) 1999-01-26
SK82098A3 (en) 1998-11-04
CN1072214C (zh) 2001-10-03
BR9612234A (pt) 1999-07-13
EE03440B1 (et) 2001-06-15
EP0918760A1 (en) 1999-06-02
JP2000502681A (ja) 2000-03-07
NZ325500A (en) 1999-01-28
AU704506B2 (en) 1999-04-22
NO982927L (no) 1998-06-23
CZ168498A3 (cs) 1998-09-16
US5929100A (en) 1999-07-27
IL142502A0 (en) 2002-03-10
CZ288704B6 (cs) 2001-08-15
KR19990076688A (ko) 1999-10-15
RU2177476C2 (ru) 2001-12-27
EE9800193A (et) 1998-12-15
WO1997023470A1 (en) 1997-07-03
HUP9900100A2 (hu) 1999-05-28
CA2238877A1 (en) 1997-07-03
NO982927D0 (no) 1998-06-23
GB9526511D0 (en) 1996-02-28
EP0918760B1 (en) 2001-11-28
IS4759A (is) 1998-05-27
TW401411B (en) 2000-08-11
CN1211242A (zh) 1999-03-17
HUP9900100A3 (en) 2001-10-29

Similar Documents

Publication Publication Date Title
NO996108L (no) 9-oksinerytromycinderivater
PL292095A1 (en) Pesticides and method of obtaining them
ES8404990A1 (es) Un procedimiento para la preparacion de derivados de prolina.
GB9211172D0 (en) Compounds
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
HUT64518A (en) Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
AU8912891A (en) Biologically active amines
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
MY117934A (en) Process for the preparation of n-methyl-3-(1-methyl-4- piperidinyl)-1h-indole-5-ethanesulphonamide
TW252979B (es)
BR8400549A (pt) Derivados e sais inertes de hidroxido de aminopiridinios e processos de preparacao;e composicao farmaceutica
LV10607A (lv) Jauni bicikliski aminoaizvietoti savienojumi
TW244336B (es)
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
EP0784973A3 (en) Quinoxaline derivatives for treating tinnitus
TW275629B (es)
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
HUT59415A (en) Process for producing new benzoheterocyclyl alkylaminoalkane diphosphonic acids and pharmaceutical compositions comprising same as active ingredient
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.